{"id":"standard-oral-rehydration","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypernatremia (if improperly formulated or used)"},{"rate":null,"effect":"Hyperkalemia (rare, in renal impairment)"},{"rate":null,"effect":"Nausea or vomiting (minimal with standard formulation)"}]},"_chembl":{"chemblId":"CHEMBL2108160","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"ORS works by leveraging the sodium-glucose cotransport mechanism in the small intestine, where glucose facilitates sodium absorption, which in turn drives water reabsorption osmotically. The formulation maintains physiologic electrolyte concentrations to restore intracellular and extracellular fluid balance without causing further fluid shifts. This simple, non-pharmacologic approach is the first-line treatment for mild to moderate dehydration across all age groups.","oneSentence":"Standard Oral Rehydration Solution (ORS) replaces water and electrolytes lost through dehydration by providing a balanced mixture of glucose, sodium, potassium, and chloride for intestinal absorption.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:09:29.476Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Dehydration from diarrhea and vomiting"},{"name":"Mild to moderate fluid and electrolyte loss"}]},"trialDetails":[{"nctId":"NCT07285785","phase":"PHASE4","title":"Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea","status":"RECRUITING","sponsor":"Bausch Health Americas, Inc.","startDate":"2026-02-11","conditions":"Diarrhea, Gastroenteritis, Bacterial Infection","enrollment":54},{"nctId":"NCT06137014","phase":"PHASE1, PHASE2","title":"Fortified Oral Rehydration Therapy for Pediatric Diarrhea","status":"RECRUITING","sponsor":"Paul A Breslin","startDate":"2024-06-01","conditions":"Acute Gastroenteritis","enrollment":72},{"nctId":"NCT07392931","phase":"NA","title":"Safety and Efficacy of Racecadotril in Children With Acute Watery Diarrhea","status":"COMPLETED","sponsor":"Punjab Rangers Teaching Hospital Lahore","startDate":"2025-06-01","conditions":"Acute Watery Diarrhea","enrollment":200},{"nctId":"NCT07342088","phase":"NA","title":"Lactobacillus Acidophilus and Limosilactobacillus Reuteri for Acute Diarrhea in Children","status":"COMPLETED","sponsor":"Eskisehir Osmangazi University","startDate":"2024-05-01","conditions":"Infectious Diarrhea, Acute Gastroenteritis","enrollment":145},{"nctId":"NCT07167797","phase":"NA","title":"Evaluation of the Role of Vitamin D in Reducing the Severity and Duration of Rotavirus Infection in Iraqi Children","status":"COMPLETED","sponsor":"University of Baghdad","startDate":"2025-01-01","conditions":"Rotaviral Gastroenteritis","enrollment":60},{"nctId":"NCT05166850","phase":"NA","title":"Preventative Intervention for Cholera for 7 Days","status":"RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2021-12-22","conditions":"Cholera, Water-Related Diseases, Diarrhea Infectious","enrollment":2900},{"nctId":"NCT06003816","phase":"NA","title":"Cholera-Hospital-Based-Intervention-for-7-Days (CHoBI7) Water, Sanitation, and Hygiene (WASH) Case Area Targeted Intervention (CATI)","status":"RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2023-10-18","conditions":"Cholera, Diarrhea","enrollment":3140},{"nctId":"NCT05814042","phase":"PHASE2, PHASE3","title":"Next Generation ORS: Controlled Trial Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea","status":"COMPLETED","sponsor":"University of Florida","startDate":"2023-08-21","conditions":"Diarrhea, Cholera","enrollment":396},{"nctId":"NCT04405037","phase":"PHASE4","title":"Alvimopan as a Rescue Treatment of Postoperative Ileus","status":"COMPLETED","sponsor":"Scott Steele","startDate":"2020-08-01","conditions":"Ileus, Gastrointestinal Dysfunction","enrollment":65},{"nctId":"NCT06744777","phase":"PHASE3","title":"The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2024-12-17","conditions":"Dengue Fever, Dengue Hemorrhagic Fever, Severe Dengue","enrollment":284},{"nctId":"NCT06498817","phase":"NA","title":"Testing a Scalable Model of the Cholera Hospital-Based Intervention for 7 Days (CHoBI7)","status":"RECRUITING","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2024-08-19","conditions":"Diarrhea Infectious, Cholera","enrollment":1600},{"nctId":"NCT06444633","phase":"NA","title":"The Impact of Pre-emptive Home Delivery of ORS + Zinc on Treatment for Child Diarrhea","status":"RECRUITING","sponsor":"RAND","startDate":"2024-09-04","conditions":"Diarrhea Toddler","enrollment":103920},{"nctId":"NCT04839900","phase":"NA","title":"Proactive Community Case Management for Malaria in Zambia","status":"COMPLETED","sponsor":"PATH","startDate":"2021-04-15","conditions":"Malaria, Falciparum, Malaria","enrollment":10890},{"nctId":"NCT06223191","phase":"NA","title":"Reducing Readmissions: BNI Trial in Substance Use Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universidad Nacional Autonoma de Honduras","startDate":"2024-01-29","conditions":"Substance Use Disorders, Substance Withdrawal","enrollment":150},{"nctId":"NCT04816552","phase":"NA","title":"Water, Sanitation, and Hygiene Mobile Health Messages as an Innovative Tool to Facilitate Behavior Change","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2021-03-22","conditions":"Cholera","enrollment":284},{"nctId":"NCT06179589","phase":"NA","title":"VS002A in the Treatment of Acute Watery Diarrhea in Infants and Young Children","status":"COMPLETED","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2020-12-01","conditions":"Acute Watery Diarrhoea","enrollment":312},{"nctId":"NCT03473561","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of Racecadotril in Children Aged 3 to 60 Months Suffering From Acute Diarrhea","status":"COMPLETED","sponsor":"Abbott","startDate":"2018-08-25","conditions":"Diarrhea, Infantile","enrollment":31},{"nctId":"NCT05559489","phase":"PHASE3","title":"Enteral Resuscitation Nepal","status":"UNKNOWN","sponsor":"Nepal Health Research Council","startDate":"2022-12-08","conditions":"Burn Body Region Unspecified, Burn Shock","enrollment":240},{"nctId":"NCT04732624","phase":"PHASE3","title":"Enteral Resuscitation Nepal (Pilot Study)","status":"COMPLETED","sponsor":"University of Washington","startDate":"2021-09-30","conditions":"Burn Body Region Unspecified, Burn Shock","enrollment":30},{"nctId":"NCT04677296","phase":"NA","title":"Efficacy and Safety of \"VS002A\" With the Standard WHO-ORS in Non-cholera Acute Watery Diarrhea in Infants and Young Children","status":"COMPLETED","sponsor":"Entrinsic Bioscience Inc.","startDate":"2021-06-16","conditions":"Diarrhea, Infantile","enrollment":312},{"nctId":"NCT04027894","phase":"PHASE2","title":"Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years","status":"UNKNOWN","sponsor":"RedHill Biopharma Limited","startDate":"2024-01","conditions":"Traveler's Diarrhea","enrollment":142},{"nctId":"NCT04026984","phase":"PHASE2","title":"Evaluate Safety and Efficacy of Rifamycin SV MMX in the Treatment of Traveler's Diarrhea in Children Age 6 to 11 Years","status":"UNKNOWN","sponsor":"RedHill Biopharma Limited","startDate":"2024-06","conditions":"Traveler's Diarrhea","enrollment":142},{"nctId":"NCT02742181","phase":"PHASE3","title":"Alvimopan as Rescue in Post op Ileus","status":"TERMINATED","sponsor":"Sharon Stein","startDate":"2015-12-02","conditions":"Colorectal Surgery, Ileus","enrollment":14},{"nctId":"NCT04008134","phase":"NA","title":"Cholera-Hospital-Based-Intervention-for-7-days","status":"COMPLETED","sponsor":"Johns Hopkins Bloomberg School of Public Health","startDate":"2016-12-04","conditions":"Cholera, Diarrhea, Stunting","enrollment":2626},{"nctId":"NCT05014373","phase":"PHASE3","title":"Philippine Trial to Determine Efficacy and Safety of Favipiravir for COVID-19","status":"UNKNOWN","sponsor":"University of the Philippines","startDate":"2020-10-12","conditions":"Covid19","enrollment":144},{"nctId":"NCT04695886","phase":"NA","title":"Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar","status":"UNKNOWN","sponsor":"Macfarlane Burnet Institute for Medical Research and Public Health Ltd","startDate":"2021-01","conditions":"Malaria","enrollment":6440},{"nctId":"NCT03275792","phase":"PHASE1","title":"Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion","status":"WITHDRAWN","sponsor":"University of Calgary","startDate":"2020-05","conditions":"Hemolytic-Uremic Syndrome","enrollment":""},{"nctId":"NCT04402203","phase":"PHASE2, PHASE3","title":"Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh","status":"UNKNOWN","sponsor":"Bangladesh Medical Research Council (BMRC)","startDate":"2020-05","conditions":"COVID-19, Favipiravir (Favipira)","enrollment":50},{"nctId":"NCT01785680","phase":"NA","title":"Moderate Acute Malnutrition (MAM) and Severe Acute Malnutrition (SAM) in Sierra Leone","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2013-01","conditions":"Malnutrition","enrollment":1957},{"nctId":"NCT03562702","phase":"NA","title":"Comparing Speedlyte and IV Rehydration Treating Children With Gastroenteritis in a Pediatric Emergency Department (ED)","status":"TERMINATED","sponsor":"Nicklaus Children's Hospital f/k/a Miami Children's Hospital","startDate":"2018-07-01","conditions":"Dehydration, Acute Gastroenteritis","enrollment":5},{"nctId":"NCT03463512","phase":"PHASE3","title":"Controlled Study to Evaluate the Efficacy and Safety of Racecadotril in Infants, Children and Adolescents With Acute Diarrhea","status":"COMPLETED","sponsor":"Abbott","startDate":"2018-03-29","conditions":"Diarrhea","enrollment":124},{"nctId":"NCT02870491","phase":"NA","title":"Working With Community Health Workers to Increase ORS Use in Uganda","status":"COMPLETED","sponsor":"University of California, Berkeley","startDate":"2016-08","conditions":"Infantile Diarrhea, Diarrhea, Dehydration","enrollment":7949},{"nctId":"NCT01917617","phase":"PHASE2","title":"Oral Rehydration Therapy for Short Hydration in Chemotherapy With CDDP Plus GEM for Biliary Tract Cancer","status":"COMPLETED","sponsor":"Kansai Hepatobiliary Oncology Group","startDate":"2013-05-22","conditions":"Biliary Tract Cancer","enrollment":50},{"nctId":"NCT02124265","phase":"PHASE1","title":"Oral Rehydration Therapy in Burn Patients","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2013-05","conditions":"Burn Any Degree Involving 20-29 Percent of Body Surface, Burn Any Degree Involving 30-39 Percent of Body Surface, Burn Any Degree Involving 40-49 Percent of Body Surface","enrollment":3},{"nctId":"NCT03356327","phase":"PHASE4","title":"Oral Administration of Tannins and Flavonoids in Children With Acute Diarrhea","status":"COMPLETED","sponsor":"Federico II University","startDate":"2017-04-01","conditions":"Acute Diarrhea","enrollment":60},{"nctId":"NCT01737086","phase":"PHASE2, PHASE3","title":"Comparing the Efficacy of Two Oral Rehydration Solutions, With or Without the Probiotic Lactobacillus Reuteri DSM 17938 and Zinc, on the Duration and Severity of Acute Gastroenteritis in 6 - 36 Months Old Children in Out-patient Care","status":"TERMINATED","sponsor":"Umeå University","startDate":"2012-12","conditions":"Acute Gastroenteritis","enrollment":14},{"nctId":"NCT02866097","phase":"NA","title":"Integrated Community Case Management Study in Eastern Province, Zambia","status":"UNKNOWN","sponsor":"Zambia Center for Applied Health Research and Development","startDate":"2016-03","conditions":"Malaria, Diarrhea, Pneumonia","enrollment":3840},{"nctId":"NCT01886755","phase":"NA","title":"Efficacy of an Oral Rehydration Solution Containing the Probiotic Lactobacillus Reuteri Protectis and Zinc in Infants With Acute Gastroenteritis","status":"COMPLETED","sponsor":"Alexandra Papadopoulou","startDate":"2013-07","conditions":"Acute Gastroenteritis","enrollment":51},{"nctId":"NCT02644200","phase":"PHASE3","title":"Gelatin Tannate as Treatment for Acute Childhood Gastroenteritis","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2013-06","conditions":"Acute Gastroenteritis","enrollment":60},{"nctId":"NCT00937274","phase":"NA","title":"Antibacterial Treatment Against Diarrhea in Oral Rehydration Solution","status":"TERMINATED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2009-08","conditions":"Diarrhea","enrollment":120},{"nctId":"NCT00820261","phase":"","title":"Molecular Epidemiology of Rotavirus Diarrhea Among Infants and Young Children Attending Maua Methodist Hospital, Kenya","status":"COMPLETED","sponsor":"Institute of Primate Research","startDate":"2009-08","conditions":"Rotavirus","enrollment":630},{"nctId":"NCT01025583","phase":"PHASE2, PHASE3","title":"Oral Rehydration Solution With Zinc and Prebiotics in Acute Diarrhea","status":"COMPLETED","sponsor":"Federico II University","startDate":"2007-11","conditions":"Diarrhea","enrollment":130}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":41,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standard Oral Rehydration","genericName":"Standard Oral Rehydration","companyName":"Federico II University","companyId":"federico-ii-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standard Oral Rehydration Solution (ORS) replaces water and electrolytes lost through dehydration by providing a balanced mixture of glucose, sodium, potassium, and chloride for intestinal absorption. Used for Dehydration from diarrhea and vomiting, Mild to moderate fluid and electrolyte loss.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}